Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000489698 | SCV000577267 | uncertain significance | not provided | 2020-06-04 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In-silico analysis, which includes splice predictors and evolutionary conservation, is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown. |
Invitae | RCV000634956 | SCV000756330 | likely benign | Lysinuric protein intolerance | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000634956 | SCV001266543 | uncertain significance | Lysinuric protein intolerance | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Genome- |
RCV000634956 | SCV002045741 | uncertain significance | Lysinuric protein intolerance | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002263700 | SCV002542961 | uncertain significance | Autoinflammatory syndrome | 2021-02-18 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000489698 | SCV001742663 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000489698 | SCV001926280 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000489698 | SCV001971126 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000634956 | SCV002091180 | uncertain significance | Lysinuric protein intolerance | 2020-01-16 | no assertion criteria provided | clinical testing |